Related Experiment Video
Updated: Jul 27, 2026

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
Published on: March 17, 2008
A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development
V K Gupta1, T E Beckert, J C Price
1Department of Pharmaceutical and Biomedical Sciences, University of Georgia, College of Pharmacy, Athens, GA 30602, USA. vishal.k.gupta@monsanto.com
This study developed a novel colon drug delivery system using polymethacrylates for sustained release of 5-aminosalicylic acid (5-ASA). The system effectively delayed drug release until the colon
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Polymer Chemistry
Background:
- Targeted drug delivery to the colon remains a challenge.
- Polymethacrylates offer tunable pH-dependent dissolution properties for controlled release.
- 5-aminosalicylic acid (5-ASA) is a key therapeutic agent for inflammatory bowel disease.
Purpose of the Study:
- To develop and evaluate a novel pH-triggered drug delivery system for colon-specific delivery of 5-ASA.
- To utilize polymethacrylates with specific dissolution profiles for precise drug release.
- To assess the release kinetics of 5-ASA from the developed system under simulated physiological conditions.
Main Methods:
- Pellets of 5-ASA were prepared by powder layering on nonpareils.
- Pellets were coated with a combination of pH-independent (Eudragit RL/RS) and pH-dependent (Eudragit FS) polymers.
- Drug release was evaluated in phosphate buffers at various pH values after simulated gastric pre-soaking.
- Scanning electron microscopy (SEM) was used to assess coating uniformity.
Main Results:
- Coated pellets exhibited uniform polymer layers as confirmed by SEM.
- No 5-ASA release was observed for 12 hours at pH 6.5.
- Sustained drug release occurred over 12 hours at pH 7.0 and 7.5, with faster release at pH 7.5.
- A lag time was observed at pH 7.0 but not at pH 7.5.
Conclusions:
- The developed polymethacrylate-based system effectively targets the colon by preventing premature drug release.
- The combination of Eudragit RL/RS and Eudragit FS polymers ensures pH-triggered release in the distal intestine.
- This novel delivery system shows significant potential for effective colon-specific delivery of 5-ASA.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Site-Targeted
Oral Drug Delivery Systems: Continuous-Release Systems

